Lauren Schwartz

Lauren Schwartz

Auto-generated profile, based on publicly available information

Lauren Schwartz

Foundation for Prader‐Willi Research Covina California USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2021 in Journal of Neurodevelopmental Disorders
Verified
Journal Article
Open access
PDF file
LSLauren Schwartz
Lauren Schwartz
ACAssumpta Caixàs
Assumpta Caixàs
ADAnastasia Dimitropoulos
Anastasia Dimitropoulos
EDElisabeth Dykens
Elisabeth Dykens
JDJessica Duis
Jessica Duis
KWKate Woodcock
Kate Woodcock
Prader-Willi syndrome (PWS) is a rare neurodevelopmental genetic disorder associated with a characteristic behavioral phenotype that includes severe hyperphagia and a variety of other behavioral challenges such as temper outbursts and anxiety. These behaviors have a significant and dramatic impact on the daily functioning and quality of life for the person with PWS and their families. To date, effective therapies addressing these behavioral challenges have proven elusive, but several potential treatments are on the horizon. However, a limiting factor for treatment studies in PWS is the lack of consensus in the field regarding how to best define and measure the complex and interrelated behavioral features of this syndrome. The International PWS Clinical Trials Consortium (PWS-CTC, www.pwsctc.org) includes expert PWS scientists, clinicians, and patient advocacy organization representatives focused on facilitating clinical trials in this rare disease. To address the above gap in the field, members of the PWS-CTC “Behavior Outcomes Working Group” sought to develop a unified understanding of the key behavioral features in PWS and build a consensus regarding their definition and description. The primary focus of this paper is to present consensus definitions and descriptions of key phenotypic PWS behaviors including hyperphagia, temper outbursts, anxiety, obsessive–compulsive behaviors, rigidity, and social cognition deficits. Patient vignettes are provided to illustrate the interrelatedness and impact of these behaviors. We also review some available assessment tools as well as new instruments in development which may be useful in measuring these behavioral features in PWS.

29 September 2016 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
LSLauren Schwartz
Lauren Schwartz
AHAnthony Holland
Anthony Holland
EDElisabeth Dykens
Elisabeth Dykens
TSTheresa Strong
Theresa Strong
ERElizabeth Roof
Elizabeth Roof
JBJessica Bohonowych
Jessica Bohonowych
This paper reports on the ‘Prader-Willi Syndrome (PWS) Mental Health Research Strategy Workshop’ that took place in March 2015. PWS is characterized by a complex phenotype affecting multiple systems with a high prevalence of maladaptive behaviours, and neuropsychiatric illness. Prader Willi syndrome results from the absence of paternally derived alleles located at the imprinted chromosomal locus, 15q11–13. The goal of the workshop was to highlight the state of the science of the mental health of people with this rare neurodevelopmental disorder. Mental ill health and maladaptive behaviors significantly impact quality of life for persons with PWS and their caregivers. Effective treatments and further research into this area are critically needed. A multidisciplinary group of scientists and health care professionals were brought together to discuss the mental health and behavioral needs of people with PWS. The workshop strategy was to integrate established work on PWS with other relevant areas of study. The meeting also focused on two neurobiological systems that research had suggested were relevant to understanding the broader mental health aspects of PWS: the autonomic nervous system and oxytocin/vasopressin pathways. Other relevant topics were considered and recommendations made. The workshop presentations and working group discussions revealed that no one approach was sufficient to fully conceptualize the mental health challenges in PWS. Workshop discussions pointed to the need for theoretically informed studies focused on clinical characterization, measurement, and the probing of specific neurobiological systems through pharmaceutical or other interventions. Future studies in this area should explore the use of advanced neuroimaging protocols, as well as molecular studies using iPS cells in order to create more informed theories. Within this framework, workshop participants identified and prioritized key research questions, and highlighted current opportunities. Recommendations were made with respect to the development of specific resources and tools for furthering mental health research such as The Global PWS Registry, the development of effective endpoints, the use of animal models and iPS cells to aid understanding of the neurobiological underpinnings. Additionally, collaborative opportunities across disciplines and syndromes were highlighted and targeted research initiatives focused on psychological/behavioral interventions modified for use in PWS were recommended.

1 March 2025 in Journal of Applied Research in Intellectual Disabilities
Verified
Journal Article
Open access
LSLauren Schwartz
Lauren Schwartz
CVCaroline Vrana-Diaz
Caroline Vrana-Diaz
JBJessica E. Bohonowych
Jessica E. Bohonowych
Lisa MatesevacLisa Matesevac
Lisa Matesevac
TSTheresa Strong
Theresa Strong
Background: Prader–Willi syndrome (PWS) is a rare neurodevelopmental disorder with symptoms that impact health and quality of life (QOL). There is limited data on global health, QOL and the relationship with mood in individuals with PWS. Methods: Parents completed three validated assessments, the Glasgow Depression Scale‐Carer Supplement (GDS‐CS), PROMIS Parent‐Proxy Global Health 7 and PROMIS Parent‐Proxy Life Satisfaction 8b, for 527 individuals with PWS. Results: Mean GDS‐CS score was 8.29 (SD 4.55), and 18% had a score of 13+, reflective of possible depression. Mean PROMIS Global Health and Life Satisfaction scores were 41.46 (SD 8.48) and 43.39 (SD 8.48), respectively, and are lower compared to the general population. Both PROMIS scales worsened with age, and scores on the PROMIS and GDS‐CS were associated with parent reports of depression for the person with PWS. Conclusions: These validated instruments may be useful for assessing mood and QOL in PWS.

7 November 2026 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
DEDavid Evans
David Evans
JBJessica E. Bohonowych
Jessica E. Bohonowych
LSLauren Schwartz
Lauren Schwartz
TSTheresa Strong
Theresa Strong

1 May 2026 in Journal of Applied Research in Intellectual Disabilities
Verified
Journal Article
Open access
LSLauren Schwartz
Lauren Schwartz
ATAbigail TurnWald
Abigail TurnWald
MRMadelyn Roth
Madelyn Roth
TSTheresa Strong
Theresa Strong
Background: Prader‐Willi syndrome (PWS) is a complex disorder with severe behavioural symptoms that affects the entire family. Relatively little research has focused on the lived experiences of siblings growing up in this unique family environment. Method: Semi‐structured interviews were performed with 25 siblings of individuals with PWS from North America. Participants reflected on their experiences including interpersonal relationships, impacts on well‐being, coping, and relationship with food. Results: Using inductive thematic analysis, we identified several themes: (a) emotion and well‐being impacts, (b) impacts on their relationship with food, and (c) relational/social issues. Positive aspects of their family experience and impacts on job path were identified. Key coping resources were highlighted. Conclusions: This study can inform more family‐oriented support efforts in PWS care models to include sibling support. The findings suggest sibling support should focus on addressing difficult emotional experiences, problematic eating behaviours, and seeking connection with other siblings with similar experiences.